Connect with us
The outlook for the French fintech sector remains very high, with more than 80% of fintech companies anticipating growth of over 30% in both 2023 and...
The publication of the results of the phase IIa clinical trial, evaluating ABX464 in hemorrhagic recto colitis, has been driving the stock market price of Montpellier...